Official 2024 U.S. DOL Form 5500 summary for Center For Breakthrough Medicines Holdings, LLC (Center For Breakthrough Medicines 401(k) Plan · EIN 83-3099487 · PN 001): $11.91M net assets, 301 active participants, and $68.08 per $10,000 (68.08 bps).
| Plan Sponsor | Center For Breakthrough Medicines Holdings, LLC |
|---|---|
| Filing Identifier | Center For Breakthrough Medicines 401(k) Plan · EIN 83-3099487 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (PA) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $11.91M |
| Active Participants | 301 |
| Direct Admin Fee Rate | $68.08 per $10,000 (68.08 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | Main Line Retirement Advisors, Ll |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($145,528, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI